An Experimental Vaccine May Lengthen the Lives of Prostate Cancer Patients
May 1, 2009
Seattle-based Dendreon Corp. says its experimental Provenge cancer vaccine can lengthen the lives of men with advanced prostate cancer.
Topics:
Health Medical Pharma, Dendreon, Urology, Medicine, Prostate, Cancer, Prostate cancer, Sipuleucel-T, Cancer vaccine, Cancer treatments, advanced prostate cancer, Seattle, experimental Provenge cancer, Dendreon Corp.